Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2011
06/16/2011US20110144090 Compounds and methods of use thereof
06/16/2011US20110144089 Method of treating schizophrenia and other disorders
06/16/2011US20110144088 Method of treating sleep disorders
06/16/2011US20110144087 Short acting benzothiazepine calcium channel blockers and uses thereof
06/16/2011US20110144086 Inhibitors of the plasmodial surface anion channel as antimalarials
06/16/2011US20110144085 Triazolopyridine compounds as pim kinase inhibitors
06/16/2011US20110144084 6 substituted 2- heterocyclylamino pyrazine compounds as chk-1 inhibitors
06/16/2011US20110144083 Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions
06/16/2011US20110144082 Compounds for the treatment of peripheral neuropathies
06/16/2011US20110144081 Pyrrolidine derivatives
06/16/2011US20110144080 Pyrazole derivatives as protein kinase modulators
06/16/2011US20110144079 Antimicrobial system
06/16/2011US20110144078 Transition metal complexes of corroles for preventing cardiovascular diseases or disorders
06/16/2011US20110144077 Treatment of retinal degeneration
06/16/2011US20110144076 Preterm delivery diagnostic assay
06/16/2011US20110144075 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
06/16/2011US20110144074 Caspase inhibitors and uses thereof
06/16/2011US20110144073 Glucocorticoids attached to nitrate esters via an aromatic linker in position 21 and their use in ophthalmology
06/16/2011US20110144072 Antiglucocorticoid Therapy for the Prevention of Neurological Damage in Premature Infants
06/16/2011US20110144071 Crystalline active ingredient microparticles, method for producing the same and use thereof in drugs
06/16/2011US20110144070 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
06/16/2011US20110144069 Compounds for treating viral infections
06/16/2011US20110144068 3,4-diarylpyrazoles as protein kinase inhibitors
06/16/2011US20110144067 N-Acyloxysulfonamide and N-Hydroxy-N-Acylsulfonamide Derivatives
06/16/2011US20110144066 Small molecule inhibitors of the pleckstrin homology domain and methods for using same
06/16/2011US20110144065 Selective high-affinity polydentate ligands and methods of making such
06/16/2011US20110144064 Inhibitors of Kynurenine Aminotransferase and Uses Therefor
06/16/2011US20110144063 Glycerophospholipids for the improvement of cognitive functions
06/16/2011US20110144060 Substituted pyrazinone melanin concentrating hormone receptor-1 antagonists and methods
06/16/2011US20110144059 Prodrugs of 2,4-pyrimidinediamine compounds and their uses
06/16/2011US20110144057 Antagonists of the vanilloid receptor subtype 1 (vr1) and use thereof
06/16/2011US20110144056 Pyrazole derivatives useful as inhibitors of faah
06/16/2011US20110144055 Health Care
06/16/2011US20110144054 Polyol and Polyether Iron Oxide Complexes as Pharmacological and/or MRI Contrast Agents
06/16/2011US20110144053 Process for Obtaining Purified Pterostilbene and Methods of Use Thereof
06/16/2011US20110144052 Niacin prodrugs and deuterated versions thereof
06/16/2011US20110144051 Compositions and methods for treatment of mitochondrial diseases
06/16/2011US20110144050 Salts of hiv inhibitor compounds
06/16/2011US20110144049 Treating Cardiac Arrhythmias, Heart Failure, Peripheral Artery Disease and Stroke with Cyclopentyl-Triazolo-Pyrimidine or Derivative Thereof
06/16/2011US20110144048 Novel Uses of Neuraminidase Inhibitors in Infectious Diseasess
06/16/2011US20110144047 Combined method for predicting the response to an anti-cancer therapy
06/16/2011US20110144046 Anthelmintic compositions
06/16/2011US20110144045 Use of fumagillin and the derivatives thereof to increase the bioavailability of the macrocyclic lactones
06/16/2011US20110144044 Composition and method for increasing post workout recovery
06/16/2011US20110144043 Stat modulators
06/16/2011US20110144042 Novel Polysaccharides with Antithrombotic Activity Comprising at Least One Covalent Bond with Biotin or a Biotin Derivative
06/16/2011US20110144041 Methods for Treating Inflammatory Bowel Disease
06/16/2011US20110144040 Acteoside and acteoside-rich plant extracts for increasing athletic performance in humans
06/16/2011US20110144039 Antioxidative and hepatoprotective compositions containing diaryheptanoids from alnus japonica
06/16/2011US20110144037 Substrates and Inhibitors of Antiplasmin Cleaving Enzyme and Fibroblast Activation Protein and Methods of Use
06/16/2011US20110144035 Methods and Compositions for Treating Conditions of the Eye
06/16/2011US20110144033 Proteasome Inhibitors and Methods of Using the Same
06/16/2011US20110144028 Modulating cellular electrophysiology
06/16/2011US20110144027 Pharmaceutical compositions for promoting wound healing
06/16/2011US20110144016 Methods and Compositions for Treating Cancer
06/16/2011US20110144013 VEGF-D Mutants and Their Use
06/16/2011US20110144004 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections
06/16/2011US20110144003 Maintenance therapy regime/regimen for the treatment of acne
06/16/2011US20110143942 Pyrazolyl-Substituted Heterocycles and Their Use as Phytosanitary Products
06/16/2011US20110143620 Chemical Resistant Ionomers and Protective Coverings
06/16/2011US20110142974 Trigonelline as a muscle stimulant
06/16/2011US20110142967 Method of reducing blood cholesterol and triglyceride levels using combinations of vasoprotective agent
06/16/2011US20110142957 Method of treating parturient placental mammals in order to reduce maternal and/or uterine exhaustion
06/16/2011US20110142956 Use of a pde 5 inhibitor for treating and preventing hypopigmentary disorders
06/16/2011US20110142953 Combinations of immunosuppressive agents for the treatment or prevention of graft rejections
06/16/2011US20110142952 Pharmaceutical Compositions
06/16/2011US20110142951 Micelles for intracellular delivery of therapeutic agents
06/16/2011US20110142950 Polymer micelles containing anthracylines for the treatment of cancer
06/16/2011US20110142948 Nanoparticle Carrier Systems based on Human Serum Albumin for Photodynamic Therapy
06/16/2011US20110142947 Novel formulations
06/16/2011US20110142946 Drug sustained-release agent, adsorbent, functional food, mask and adsorption sheet
06/16/2011US20110142945 Hydrophobic Active Agent Compositions and Related Methods
06/16/2011US20110142943 Tamper-resistant pharmaceutical compositions of opiods and other drugs
06/16/2011US20110142941 Nanoparticle and Polymer Formulations for Thyroid Hormone Analogs, Antagonists, and Formulations and Uses Thereof
06/16/2011US20110142940 Analgesic Apatitic Calcium-Phosphate Cement
06/16/2011US20110142939 Use of a Combination of an Opioid Agonist and an Opioid Antagonist for the Treatment of Crohn's Disease and the Symptoms Associated with Crohn's Disease
06/16/2011US20110142938 Nanotubes as Mitochondrial Uncouplers
06/16/2011US20110142937 Methods and Compositions To Treat Hemorrhagic Conditions of The Brain
06/16/2011US20110142933 Controlled Release Dosage Form of Tacrolimus
06/16/2011US20110142932 Pharmaceutical Tablets Comprising a Plurality of Segments
06/16/2011US20110142931 Soft tablet containing dextrose monohydrate
06/16/2011US20110142930 Pharmaceutical Compositions of Atorvastatin
06/16/2011US20110142929 Solid pharmaceutical formulations comprising bibw 2992
06/16/2011US20110142923 Ophthalmic pharmaceutical compositions for the treatment of neoangiogenic pathologies of the eye
06/16/2011US20110142922 Stabilized composition and method for dermatological treatment
06/16/2011US20110142921 NOVEL RNAi THERAPEUTIC FOR TREATMENT OF HEPATITIS C INFECTION
06/16/2011US20110142920 Treatment of length dependent neuropathy
06/16/2011US20110142917 Compositions and methods for treatment of ear disorders
06/16/2011US20110142915 Compositions and methods for inhibition of vegf
06/16/2011US20110142914 Inhalable compositions having enhanced bioavailability
06/16/2011US20110142913 Composition and method for treating atherosclerosis, method for determining if a subject has atherosclerosis and method of screening an anti-atherosclerotic drug
06/16/2011US20110142911 HIV epitopes and pharmaceutical composition containing same
06/16/2011US20110142905 Coated tablets with remaining degradation surface over the time
06/16/2011US20110142904 Methods for the In Situ Treatment of Bone Cancer
06/16/2011US20110142899 Active nanocomposite materials and production method thereof
06/16/2011US20110142890 Nanoparticles of chitosan and hyaluronan for the administration of active molecules
06/16/2011US20110142889 Compositions and methods for oral drug delivery
06/16/2011US20110142886 Pegylated polyplexes for polynucleotide delivery
06/16/2011US20110142883 Amorphous Coprecipitates of Atorvastatin Pharmaceutically Acceptable Salts
06/16/2011US20110142880 Lentivirus-based immunogenic vectors
1 ... 1689 1690 1691 1692 1693 1694 1695 1696 1697 1698 1699 1700 1701 1702 1703 1704 1705 1706 1707 1708 1709 ... 7860